XML 29 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
9 Months Ended
Nov. 01, 2014
Stock-Based Compensation [Abstract]  
Share-Based Compensation

Note 5 - Stock-Based Compensation

 

Stock-based compensation includes stock options, cash-settled stock appreciation rights (SARs) and restricted stock awards. Additionally, we recognize stock-based compensation expense for the discount on shares sold to employees through our employee stock purchase plan. For the thirteen and thirty-nine weeks ended November 1, 2014, stock-based compensation expense for the employee stock purchase plan was $8,000 before the income tax benefit of $3,000 and $28,000 before the income tax benefit of $11,000, respectively. For the thirteen and thirty-nine weeks ended November 2, 2013, stock-based compensation expense for the employee stock purchase plan was $7,000 before the income tax benefit of $3,000 and $29,000 before the income tax benefit of $11,000, respectively.

 

The following table summarizes the share transactions for our restricted stock awards:

 

         Number of
Shares
  Weighted-
Average Grant
Date Fair
Value
Restricted stock at February 1, 2014       525,259     $ 19.84  
   Granted       212,060       25.55  
   Vested       (2,416 )     22.54  
   Forfeited       (16,400 )     21.71  
Restricted stock at November 1, 2014       718,503     $ 21.47  
 

The weighted-average grant date fair value of stock awards granted during the thirty-nine-week periods ended November 1, 2014 and November 2, 2013 was $25.55 and $20.80, respectively. The total fair value at grant date of previously non-vested stock awards that vested during the first nine months of fiscal 2014 was $54,000. The total fair value at grant date of previously non-vested stock awards that vested during the first nine months of fiscal 2013 was $2.3 million.

 

The following section summarizes information regarding stock-based compensation expense recognized for restricted stock awards:

 

(In thousands)       Thirteen
Weeks Ended
November 1,
2014
      Thirteen
Weeks Ended
November 2,
2013
      Thirty-nine
Weeks Ended
November 1,
2014
  Thirty-nine
Weeks Ended
November 2,
2013
Stock-based compensation expense before the recognized income tax benefit   $ (1,555 )   $ 719     $ 259     $ 2,425  
Income tax benefit   $ (608 )   $ 278     $ 102     $ 926  

 

During the third quarter of fiscal 2014, we recognized a $1.6 million reduction in expense, which was comprised of stock-based compensation expense of $732,000 offset by an expense reversal of $2.3 million.  The reduction in expense was attributable to our reversal of our cumulative prior period expense for performance-based awards, which were deemed by management as not probable of vesting prior to their expiration.

 

As of November 1, 2014, approximately $8.1 million of unrecognized compensation expense remained related to both our performance-based and service-based restricted stock awards. The cost is expected to be recognized over a weighted average period of approximately 3.5 years. This incorporates our current assumptions with respect to the estimated requisite service period required to achieve the designated performance conditions for performance-based stock awards.

 

The following table summarizes the SARs activity:

 

         Number of
Shares
  Weighted-
Average
Exercise Price
  Weighted-
Average
Remaining
Contractual
Term (Years)
Outstanding at February 1, 2014       78,750     $ 17.17          
     Granted       0       0.00          
     Forfeited       0       0.00          
     Exercised       (37,750 )     17.17          
Outstanding at November 1, 2014       41,000     $ 17.17       2.24  
                           
Exercisable at November 1, 2014       1,625     $ 17.17       2.24  

 

The fair value of these liability awards are remeasured, using a trinomial lattice model, at each reporting period until the date of settlement. Increases or decreases in stock-based compensation expense are recognized over the vesting period, or immediately for vested awards. The weighted-average fair value of outstanding, non-vested SAR awards was $3.61 as of November 1, 2014.

 

The following table summarizes information regarding stock-based compensation expense recognized for SARs:

 

 

(In thousands)       Thirteen
Weeks Ended
November 1,
2014
      Thirteen
Weeks Ended
November 2,
2013
      Thirty-nine
Weeks Ended
November 1,
2014
  Thirty-nine
Weeks Ended
November 2,
2013
Stock-based compensation expense before the recognized income tax benefit   $ 26     $ 59     $ 5     $ 208  
Income tax benefit   $ 10     $ 23     $ 2     $ 79

 

As of November 1, 2014, approximately $14,000 in unrecognized compensation expense remained related to non-vested SARs. This expense is expected to be recognized over a weighted-average period of approximately 0.3 years.